Clinical Trial

Safety and Efficacy of MILEP Versus Standard EEP

Study acronym: MILES
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 21, 2025 (before its estimated March 2025 completion). Its status may not reflect the trial's current state.
Summary
Endoscopic enucleation of the prostate (EEP) is a standard treatment for benign prostatic hyperplasia (BPH), with modifications such as MiLEP that utilizes smaller instruments. The reduced resectoscope diameter in MiLEP may help decrease rates of stress urinary incontinence (SUI) and urethral strictures. Objective: to compare the efficacy and safety of MiLEP and standard EEP with a thulium fiber laser (TFL).
Trial Details
NCT Number NCT06839768
Lead Sponsor Sechenov University
Collaborators: Hospital Pompeia
Conditions Benign Prostate Hypertrophy(BPH), LUTS(Lower Urinary Tract Symptoms)
Enrollment 340 participants
Start Date 2024-03-14
Primary Completion 2025-03 (estimated)
Study Completion 2025-05 (estimated)
Updated on ClinicalTrials.gov 2025-02-21